Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1

Explore clinical trials studying Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 trial results

Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions: Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations: Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Institut Bergonie Bordeaux, France

Centre Georges-Francois-Leclerc Dijon, France

View all 25 locations

View Trial Details

Granuloma (1)
Granuloma, Plasma Cell (1)
Hemic and Lymphatic Diseases (1)
Immune System Diseases (1)
Immunoproliferative Disorders (1)
Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma (1)
Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma (1)
Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma (1)

Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1

Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 trial results

CREATE: Cross-tumoral Phase 2 With Crizotinib

Related conditions